She Chang-Shou, Deng Yue-Lin, Huang Guo-Qing, Cheng Chao, Zhang Fang-Jie
Department of Emergency Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
Department of Clinical Laboratory, Lixian People's Hospital, Changde, Hunan, People's Republic of China.
Int J Gen Med. 2022 Feb 15;15:1565-1573. doi: 10.2147/IJGM.S350361. eCollection 2022.
This study's goal was to explore risk factors affecting short-term prognosis of cardiorenal syndrome type 1 (CRS1) in acute myocardial infarction (AMI) patients.
In this retrospective analysis of CRS1 in AMI patients hospitalized from January 2011 to December 2014, the patients were classified into deceased or survivor groups. Clinical data, including demographics, laboratory results, and 28-day outcomes, were collected.
The incidence rate of CRS1 in AMI patients was 15.2% (274 in 1801). Ultimately, 88 patients were enrolled and 25 (28.4%) were classified into the deceased group, while 63 were classified into the survivor group. There were statistically significant differences between the groups for hypertension, mechanical ventilation, KIDGO stage, NT-proBNP, Hb, ALB, PCI, decreased LVEF, 7th-day SCr value, and the highest SCr value recorded within 7 days (all < 0.05). Multivariate logistic regression showed that the following factors were significantly related to whether a patient died: requiring mechanical ventilation, increased NT-proBNP levels and 7th-day SCr values, and decreased LVEFs. The APACHE II, SOFA, and SASP II scores on the 7th day were significantly higher in the deceased group (all < 0.05). The accuracy of APACHE II, SOFA, and SASP II scores on the 7th day for predicting death were 84.1%, 78.4% and 79.5%, respectively. The AUC of 7th-day APACHE II, SOFA, and SASP II scores was 0.844, 0.803, and 0.827, respectively, with no statistically significant differences between the three scores ( > 0.05).
The mortality rate of CRS1 in AMI patients was 28.4% (25 in 88) within 28 days. Mechanical ventilation, increased NT-proBNP levels, the 7th-day SCr value, and decreased LVEF were related to death in AMI patients with CRS1. APACHE II, SOFA, and SAPS II scores on the 7th day were satisfactorily accurate in predicting death within 28 days.
本研究旨在探讨影响急性心肌梗死(AMI)患者1型心肾综合征(CRS1)短期预后的危险因素。
对2011年1月至2014年12月住院的AMI患者中的CRS1进行回顾性分析,将患者分为死亡组和存活组。收集临床资料,包括人口统计学、实验室检查结果及28天预后情况。
AMI患者中CRS1的发生率为15.2%(1801例中有274例)。最终纳入88例患者,其中25例(28.4%)被归入死亡组,63例被归入存活组。两组在高血压、机械通气、KIDGO分期、NT-proBNP、血红蛋白、白蛋白、PCI、左心室射血分数降低、第7天血清肌酐值以及7天内记录的最高血清肌酐值方面存在统计学显著差异(均P<0.05)。多因素logistic回归显示,以下因素与患者是否死亡显著相关:需要机械通气、NT-proBNP水平升高、第7天血清肌酐值升高以及左心室射血分数降低。死亡组第7天的急性生理与慢性健康状况评分系统II(APACHE II)、序贯器官衰竭评估(SOFA)和简化急性生理学评分II(SAPS II)评分均显著更高(均P<0.05)。第7天APACHE II、SOFA和SAPS II评分预测死亡的准确率分别为84.1%、78.4%和79.5%。第7天APACHE II、SOFA和SAPS II评分的曲线下面积(AUC)分别为0.844、0.803和0.827,三者之间无统计学显著差异(P>0.05)。
AMI患者中CRS1在28天内的死亡率为28.4%(88例中有25例)。机械通气、NT-proBNP水平升高、第7天血清肌酐值以及左心室射血分数降低与CRS1的AMI患者死亡相关。第7天的APACHE II、SOFA和SAPS II评分在预测28天内死亡方面具有令人满意的准确性。